The Brazilian Reproducibility Network
Authors:
- Clarissa F.D. CarneiroCCClarissa F.D. Carneiro
- Eduarda G.Z. CentenoECEduarda G.Z. Centeno
- Tulio GoisTGTulio Gois
- Daniel UmpierreDUDaniel Umpierre
- Michael AndradesMAMichael Andrades
- Viviane VeigaVVViviane Veiga
- Ricardo CenevivaRCRicardo Ceneviva
- Roberta AndrejewRARoberta Andrejew
- Renato SantosRenato Santos
- Olavo B. AmaralOAOlavo B. Amaral
Open Access
- 1 January 2026
- journal article
- Published by FapUNIFESP (SciELO) in Anais da Academia Brasileira de Ciências
- Vol. 98 (suppl 1) , e20251108
Abstract
The movement for open and reproducible science has promoted several changes in the scientific ecosystem. The Brazilian Reproducibility Network (BrRN), created in 2023, seeks to consolidate these efforts at a national level, promoting a collaborative environment for activism, development of educational resources and metascience. The BrRN encompasses institutions, scientific societies and journals, groups and individuals who are engaged in promoting common values in various areas of knowledge and regions of the country. In this article we present the background to the formation of the BrRN and its activities in its first two years of existence. We hope that the project will contribute to more reliable, responsible and rigorous science in Brazil through collaborative, transparent and reproducible practices.Keywords
Funding Information
- Instituto Serrapilheira
This publication has 27 references indexed in Scilit:
- Metascience as a Scientific Social MovementMinerva, 2023
- Open science, done wrong, will compound inequitiesNature, 2022
- The reproducible normality of the crystallographic B-factorAnalytical Biochemistry, 2022
- Rein in the four horsemen of irreproducibilityNature, 2019
- 1,500 scientists lift the lid on reproducibilityNature, 2016
- Investigating Variation in ReplicabilitySocial Psychology, 2014
- Scientific method: Statistical errorsNature, 2014
- Biomedical research: increasing value, reducing wasteThe Lancet, 2014
- Raise standards for preclinical cancer researchNature, 2012
- Believe it or not: how much can we rely on published data on potential drug targets?Nature Reviews Drug Discovery, 2011